Literature DB >> 16731429

Cross-calibration and minimum precision standards for dual-energy X-ray absorptiometry: the 2005 ISCD Official Positions.

John A Shepherd1, Ying Lu, Kevin Wilson, Thomas Fuerst, Harry Genant, Thomas N Hangartner, Charles Wilson, Didier Hans, Edward S Leib.   

Abstract

The International Society for Clinical Densitometry (ISCD) Committee on Standards of Bone Measurement (CSBM) consists of experts in technical aspects of bone densitometry. The CSBM recently reviewed the scientific literature on cross-calibration and precision assessment. A report with recommendations was presented at the 2005 ISCD Position Development Conference (PDC). Based on a thorough review of the data by the ISCD Expert Panel during the conference, the ISCD adopted Official Positions with respect to (1) cross-calibration when changing or replacing hardware; (2) the approach to cross-calibration when an entire system is changed to one made by either the same or a different manufacturer; (3) when no cross-calibration study or bone mineral density (BMD) comparison is done between facilities; and (4) the minimum acceptable precision for an individual technologist. We present here the ISCD Official Positions on these topics that were established as a result of the 2005 PDC, together with the associated rationales and supportive evidence.

Entities:  

Mesh:

Year:  2006        PMID: 16731429     DOI: 10.1016/j.jocd.2006.05.005

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  33 in total

1.  BMD measurement and precision: a comparison of GE Lunar Prodigy and iDXA densitometers.

Authors:  Diane Krueger; Nellie Vallarta-Ast; Mary Checovich; Dessa Gemar; Neil Binkley
Journal:  J Clin Densitom       Date:  2011-11-09       Impact factor: 2.617

2.  Official positions of the International Society for Clinical Densitometry.

Authors:  E Michael Lewiecki; Neil Binkley; John P Bilezikian; David L Kendler; Edward S Leib; Steven M Petak
Journal:  Osteoporos Int       Date:  2006-08-18       Impact factor: 4.507

3.  Prevalence and risk factors of radiographic vertebral fracture in Brazilian community-dwelling elderly.

Authors:  J B Lopes; C F Danilevicius; L Takayama; V F Caparbo; P R Menezes; M Scazufca; M E Kuroishi; R M R Pereira
Journal:  Osteoporos Int       Date:  2010-05-05       Impact factor: 4.507

4.  Pulse-echo ultrasound method for detection of post-menopausal women with osteoporotic BMD.

Authors:  J P Karjalainen; O Riekkinen; H Kröger
Journal:  Osteoporos Int       Date:  2018-02-19       Impact factor: 4.507

5.  DXA evaluation of femoral bone mineral density and cortical width in patients with prior total knee arthroplasty.

Authors:  T Blaty; D Krueger; R Illgen; M Squire; B Heiderscheit; N Binkley; P Anderson
Journal:  Osteoporos Int       Date:  2018-08-31       Impact factor: 4.507

6.  Reproducibility of DXA measurements of bone mineral density and body composition in children.

Authors:  Cheryl M Leonard; Melissa A Roza; Ronald D Barr; Colin E Webber
Journal:  Pediatr Radiol       Date:  2008-12-04

7.  Prevalence of sarcopenia and associated risk factors by two diagnostic criteria in community-dwelling older men: the São Paulo Ageing & Health Study (SPAH).

Authors:  C P Figueiredo; D S Domiciano; J B Lopes; V F Caparbo; M Scazufca; E Bonfá; R M R Pereira
Journal:  Osteoporos Int       Date:  2013-07-27       Impact factor: 4.507

Review 8.  Common mistakes in the clinical use of bone mineral density testing.

Authors:  E Michael Lewiecki; Nancy E Lane
Journal:  Nat Clin Pract Rheumatol       Date:  2008-10-21

Review 9.  Bone physiology, disease and treatment: towards disease system analysis in osteoporosis.

Authors:  Teun M Post; Serge C L M Cremers; Thomas Kerbusch; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

10.  Regional differences in hip bone mineral density levels in Norway: the NOREPOS study.

Authors:  T K Omsland; C G Gjesdal; N Emaus; G S Tell; H E Meyer
Journal:  Osteoporos Int       Date:  2008-07-17       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.